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Introduction
Overhydrated hereditary stomatocytosis (OHSt), which is
clinically characterized by a hemolytic anemia, is a rare dis-
order of red blood cells (RBCs) associated with increased
membrane permeability to monovalent cations and
increased activity of the Na+K+-ATPase.1 OHSt diagnosis is
based on a hemolytic anemia associated with a massive right
shift of the osmotic gradient ektacytometry curve and a
decreased osmotic resistance, together with a major increase
in a monovalent cation leak. Blood smears show stomato-
cytes and bowl-shaped RBCs presenting a slit-like area.
OHSt is associated with mutations in the gene encoding the
Rh-associated glycoprotein (RhAG), a member of the Rh
complex.2 RhAG may function as an ammonium transporter
and/or a gas channel.3-5 When expressed in Xenopus laevis
oocytes, the human wild-type RhAG induces a monovalent
cation leak considerably enhanced when mutated RhAG
transporters are expressed instead.2 Among membrane
abnormalities, OHSt RBCs display a sharp reduction or an
absence of stomatin,6 an integral RBC membrane protein. In
human RBCs, stomatin acts as a molecular switch that partly
converts the glucose transporter 1 (Glut1) into a transporter
for L-dehydroascorbic acid (DHA) that is metabolized pro-
ducing ascorbate. In the absence of stomatin, the DHA trans-
port by Glut1 undergoes a 2-fold decrease while glucose
uptake is significantly increased,7 suggesting an enhanced
glycolysis in OHSt RBCs. Altogether, these results indicate
that the OHSt physiopathology affects several metabolic
pathways in RBCs and may disrupt homeostasis of RBC
metabolism. We have developed a simple strategy for the
extraction and global mass spectrometry-based analyses of
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Overhydrated hereditary stomatocytosis, clinically character-
ized by hemolytic anemia, is a rare disorder of the erythrocyte
membrane permeability to monovalent cations, associated
with mutations in the Rh-associated glycoprotein gene. We
assessed the red blood cell metabolome of 4 patients with this
disorder and showed recurrent metabolic abnormalities asso-
ciated with this disease but not due to the diminished half-life
of their erythrocytes. Glycolysis is exhausted with accumula-
tion of ADP, pyruvate, lactate, and malate. Ascorbate metabol-
ic pathway is altered probably due to a limited entry of dehy-
droascorbate. Although no major oxydative stress has been
reported in patients with overhydrated hereditary stomatocy-
tosis, we found decreased amounts of oxydized glutathione,
creatine and ergothioneine, suggesting transporter abnormali-
ties and/or uncharacterized oxydative stress. These results
pinpoint major metabolic defects of overhydrated hereditary
stomatocytosis erythrocytes and emphasize the relevance of
red blood cell metabolomics for a better understanding of the
pathophysiological bases of hemolytic anemia associated with
erythrocyte abnormalities. 
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ABSTRACT
metabolites from purified human RBCs.8 Here we use this
strategy to distinguish metabolic changes in RBCs from
OHSt patients in order to fully characterize the metabolic
bases of this disease. 
Design and Methods 
Blood samples were collected from 4 French patients (3 males
and one female) from three different families2 carrying the
Phe65Ser mutation in RhAG, and 24 healthy adults as controls,
including 5 relatives of the patients. Hemoglobin levels of the
patients were between 9.9 and 12.7g/dL with an average of 11.3
g/dL. Reticulocyte count (325¥109/L, range 269-445¥109/L; 10.8%,
range 7.5-15.8%) and the mean red cell volume of the patients had
increased (134 fL, range 122-144 fL). Written informed consent
was obtained from all patients and controls in accordance with the
Declaration of Helsinki. 
Preparation of RBC lysates, metabolite extraction from RBCs,
parameters for liquid chromatography coupled to electrospray-
LTQ-Orbitrap mass spectrometry, and data processing were per-
formed as previously described.8 Control RBCs were fractioned
according to the age of the RBCs.9 The percentage of leukocytes in
RBC purified samples was determined using an automated cell
counter (Abacus Junior Hematology Analyzer, Diatron). For all
samples, the percentage of leukocytes was less than 0.01%.
Results and Discussion 
Red blood cell metabolites from OHSt patients and con-
trols were analyzed by LC/MS with detection in both ion
modes: negative and positive. Detected biomolecules are
amino acids, organic acids, amines, lipids, sugars, hor-
mones, peptides, and proteins. The selectivity of metabo-
lite detection is obtained from the chromatographic reten-
tion time and to the accuracy of mass measurements.
Processing of the metabolic fingerprints led to 1524 and
785 relevant ions in the negative and positive ion modes,
respectively. The hundreds of thousands of signals con-
tained in the data sets make statistical analysis problemat-
ic. The resulting data matrices were subjected to multivari-
ate statistical analyses using Principal Component
Analysis (PCA), an unsupervised method that can summa-
rize the information content of the original data set and
visualize it in a 2-dimensional space.10 As shown in Figure
1A, the PCA score plot discriminated the healthy subjects
(green diamonds) from the OHSt patients (blue squares)
on the basis of the information obtained from the meta-
bolic fingerprints.
Eighty-nine metabolites were identified from the meta-
bolic fingerprints.8 Twenty-nine displayed significantly
decreased (Figure 1B) or increased (Figure 1C) concentra-
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Figure 1. OHSt patients and healthy subjects can be discrim-
inated on the basis of the metabolic information contained
in their red blood cells. (A) PCA score plots for RBC extracts
obtained from 4 OHSt patients and 24 controls including
patients’ relatives. Each point (blue squares: OHSt patients;
green diamonds: healthy subjects) represents an LC/MS
metabolic fingerprint. Data were acquired in negative mode
of electrospray ionization. Variables included in the resulting
data matrix were mean-centered and scaled to unit variance
before PCA. Scores plot separates metabolic fingerprints of
healthy subjects from those of OHSt patients on the first
component, indicating that most of the variance of the data
set correlates with OHSt. 
(B-C) A metabolic signature of OHSt patients is obtained from LC/MS analysis of RBC extracts. Metabolites exhibiting significant concentra-
tion variations between controls and OHSt patients are shown. Values are ratios of individual levels observed for OHSt patients (blue point)
and controls (green, mean with 95% CI) to mean levels obtained for healthy subjects. (B) Metabolites whose levels are decreased in OHSt
patients. (C) Metabolites whose levels are increased in OHSt patients. 
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tions in OHSt patients compared with controls. No signif-
icant metabolite concentration differences were found
between RBC extracts from OHSt patients with low
(7.5%) and high (15.8%) reticulocyte count (data not
shown) indicating that the differences observed were not
directly related to the number of reticulocytes present in
the analyzed samples. A similar absence of effect of retic-
ulocyte concentration on the RBC metabolome was found
in a previous study on sickle cell disease.8
To ensure that this metabolic signature was directly
related to OHSt and not to the diminished half-life of
OHSt RBCs (data not shown), we compared the
metabolomes of young RBCs, i.e. less than 20-day old
cells, containing 1.6% reticulocytes, from healthy sub-
jects to those of OHSt patients’ RBCs. To this end, con-
trol’s RBCs were fractioned according to their ages9 and
the metabolomes of the different fractions were ana-
lyzed by LC/MS. Then, for each discriminating metabo-
lite previously identified, we compared the metabolite
concentration ratio of OHSt patients’ RBCs on controls’
RBCs with the ratio of young fraction on all fractions in
normal RBCs. Metabolites exhibiting comparable con-
centration ratios were considered to have been impacted
by the age of RBCs. This analysis showed that the con-
centration of metabolites, such as GSH, desoxy-ribose-5-
phosphate, aspartate, leucine, spermine or threonate,
was related to the youth of OHSt RBCs and not to intrin-
sic metabolic disorders of OHSt patients’ RBCs (Figure
2A and B). 
In the glycolytic and pentose phosphate pathways, we
detected decreased concentrations of many metabolic
intermediates, such as hexose-1,6-bisphosphate, phospho-
glycerate, i.e. 2-phospho-glycerate or 3-phospho-
glycerate, or desoxy-ribose-5-phosphate (Figures 1B and
3A), while others, like hexose-6-phosphate, glyceralde-
hyde-3-phosphate, bisphospho-glycerate, phospho-
enolpyruvic acid and disphosphoglyceric acid,  did not
vary (Figure 3A). All final products of glycolysis, i.e. pyru-
vate, lactate and malate (which can be produced from
pyruvate), displayed higher concentrations in OHSt
patients’ RBCs (Figures 1C, and 3A) than in controls’
RBCs. As RBCs of the OHSt patients display a very high
activity of the Na+K+-ATPase, thought to compensate for
the monovalent cation leakage associated with the mutat-
ed RhAG transporter, these results are consistent with the
high levels of ATP required for the Na+K+-ATPase activity,1
ATP production only depending on glycolysis in RBCs.
Interestingly, we did not observe any variations in concen-
tration of glycolysis end-products, such as pyruvate or lac-
tate, in sickle cell disease RBCs,8 strongly suggesting that
Metabolome of overhydrated stomatocytic red blood cells
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Figure 2. A metabolic signature of
OHSt patients and of young normal
RBCs can be obtained from LC/MS
analysis of RBC extracts. Metabolites
showing significant concentration vari-
ations between controls and OHSt
patients are shown. (A) Metabolites
whose levels had decreased in OHSt
patients were analyzed in young nor-
mal RBCs. (B) Metabolites whose lev-
els had increased in OHSt patients
were analyzed in young normal RBCs.
Values are ratios of mean levels
observed for OHSt patients and con-
trols (gray panel), compared to ratios
of mean levels found for young RBCs
and all aged RBCs (hatched panel).
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the alteration in the concentrations of these glycolysis
end-products was related to specific alterations of OHSt
patients’ RBCs. 
Because of the reduction or absence of stomatin in OHSt
patients’ RBC membranes, the DHA transport by the
Glut1 transporter decreases.7 Although DHA could not be
detected by the method used, the ascorbate concentration
underwent a 1.7-fold decrease in OHSt patients’ RBCs
together with an increase in the concentrations of thre-
onate and threonolactone; two metabolites originating
from ascorbate degradation products (Figures 1B and C,
and 3B). The same decrease in threonate concentration
was found in young erythrocytes compared to whole RBC
population, thus indicating the relative impacts of OHSt
and age of RBCs on the increase or decrease of the
metabolite concentrations detected. Finally, the variations
in the concentration of metabolites that are part of the
ascorbate pathway were moderate explaining why,
despite the decreased uptake of DHA by OHSt patients’
RBCs, no clinical manifestation of an ascorbate deficit in
OHSt patients was reported. 
The moderate decrease in reduced glutathione (GSH)
concentration found in OHSt patients’ RBCs is in line with
decreased RBC GSH concentration in 3 cases of hemolytic
anemia11 and is consistent with the decrease in GSH con-
centration probably being linked to the young age of
OHSt patients’ RBCs (Figure 2A). We also found a 12-fold
decrease of oxydized glutathione (GSSG) concentration
(Figures 1B and 3A and B). This variation might be due to
an increased GSSG efflux from RBCs, given that the mem-
brane GSSG efflux transporter MRP1 is ATP-dependent
and has a higher affinity for GSSG than for GSH.12 As
OHSt RBCs are known to produce more ATP than normal
RBCs,1 the efflux of GSSG through MRP1 might increase. 
Only two amino acids (glutamine and tryptophan)
showed increased concentrations in OHSt patients’ RBCs
(Figures 1C and 3C), whereas the concentrations of
glycine, serine, glutamate, alanine, choline, valine, tyro-
sine, phenylalanine, histidine, asparagine, and lysine
remained unchanged. Carnitine and acetyl-carnitine con-
centrations had increased in OHSt cells (Figures 1C and
3C) which might indicate increased membrane turnover.
D. Darghouth et al.
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Figure 3. Alterations in RBC pathways. Metabolites in red increased in OHSt patients RBCs versus control. Metabolites in blue decreased in
OHSt patients RBCs versus control. Metabolites in black stayed unchanged in OHSt patients’ RBCs versus control. Metabolites with one aster-
isk (*) were not observed in our study. Metabolites with two asterisks (**) cannot be set apart from their isomers in our study. Metabolites
with a double cross (‡) are related to RBC ages and not to OHSt. The solid black arrow indicates an enzymatic transformation and the
dashed blue arrow indicates a facilitated diffusion (passive transport) through the erythrocyte membrane. The solid blue arrow indicates a
secondary active transport through the erythrocyte membrane. (A) GSH metabolism, glycolytic activity and pentose phosphate pathway. (B)
Ascorbate metabolism. (C) Amino-acid transport by erythrocyte membrane and role of carnitine in cell membrane turnover. 
A B
C
A decreased concentration of creatine (Figures 1B, 2A and
3C) was detected in OHSt patients’ RBCs. Creatine has
been reported to be a youth marker in RBCs13 and in
hemolytic anemia. Creatine concentration is expected to
increase due to the short RBC lifespan (see also in sickle
cell anemia8). This discrepancy might be the consequence
of a lower intake of creatine dependent on the sodium gra-
dient,14 itself altered in OHSt  RBCs.15
Finally, we found a decreased concentration of ergoth-
ioneine in OHSt patients’ RBCs. Ergothioneine is synthe-
sized from histidine in organisms such as actinobacteria or
filamentous fungi16 but not in humans in whom its pres-
ence is due to dietary intake.17 Ergothioneine has anti-oxi-
dant properties and is imported into human cells like ery-
throcytes by a specific transporter (OCTN1).18 The
decreased concentrations of ergothioneine observed in
OHSt patients’ RBCs may be linked to a decreased
OCTN1 activity or to an increased consumption compen-
sating for the decreased concentration of GSSG in OHSt
patients’ RBCs.
In conclusion, the metabolic signature of OHSt patients’
RBCs provided new insights into their molecular alter-
ations, including increased GSSG efflux, decreased creatine
transport, accumulation of glutamine and tryptophan, and
decreased concentration of ergothioneine. Some of the
metabolomic alterations found in the OHSt patients’ RBCs,
such as GSH or desoxyribose 5P variations, are also found
both in young normal RBCs and in sickle cell disease RBCs.
This strongly suggests that these alterations are related to
the young age of RBCs in these 2 hemolytic anemias.
Conversely other alterations, such as pyruvate or lactate
variations, were found only in the metabolic signature of
OHSt patients’ RBCs, and not in sickle cell disease patients’
RBCs, suggesting that these alterations are linked to OHSt
patients’ RBCs phenotype. Finally, this study demonstrates
that RBC metabolomics could be an appropriate and useful
method to assess large cohorts of patients with frequent
pathologies, like sickle cell disease,8 as well as patients with
rare diseases such as OHSt, for which specific metabolom-
ic signatures were obtained from 4 patients.
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